HealthMore in Health→
In vivo CAR-T dominates conference attention, but the field remains preclinical
Coverage from the American Society of Gene and Cell Therapy meeting suggests in vivo CAR-T is becoming one of the field's biggest themes, even though the work is still largely preclinical.
Key Takeaways
- Endpoints News says in vivo CAR-T was a major theme at the ASGCT annual meeting in Boston.
- The same report stresses that the work is still preclinical.
DE
DT Editorial Team··via endpoints.news